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Several studies in developed countries have reported increases in 
mental health problems such as anxiety, depression, sleeplessness, and 
post-traumatic stress disorder among flood victims [6]. A recent survey 
of flooded individuals and a reference group of non-flooded individuals 
from the same area of residence in the United Kingdom [8] found a 
fourfold increase in psychological distress among adults whose homes 
were flooded compared with those whose homes were not (RR=4.1, 95% 
CI: 2.6,6.4). The risk estimates for physical illness in adults declined 
after adjustment for psychological distress, while psychological distress 
remained strongly associated with flooding after adjustment for physical 
illnesses. Other previous studies reported behaviour change in children 
as increased bedwetting and aggression [9].
There is some evidence that diarrhoea disease increases after 
flooding, particularly in developing countries, but also in Europe [6]. A 
recent UK study reported an increase in self-reported gastroentereritis 
associated with flooding and with increasing risk the greater the 
depth of household flooding (RR 1.7 [0.9,3.0] p for trend by flood 
depth = 0.04) and an increase in earache (RR 2.2 [1,1,4.1]) [7]. The 
large displacement of population that occurs after flooding, and poor 
sheltering conditions and crowding may also contribute to increase 
the risk of diarrhoeal and respiratory infections.Other studies refer to 
evidence of flood-associated outbreaks of leptospirosis in a wide range 
of countries, including Portugal (1969), the Russian Federation (1997), 
and the Czech Republic (2003) [3,6,10]. Transmission is believed to be 
promoted by skin and mucous membrane contact with water, damp 
soil, vegetation or mud contaminated with rodent urine. Prompt 
recognition of the disease and early treatment of cases is essential to 
minimise the impact of the outbreak. 
Floods may lead indirectly to an increase in vectorborne diseases 
through the expansion in the number and range of vector habitats. 
Standing water caused by heavy rainfall or overflow of rivers can act as 
breeding sites for mosquitoes, and therefore enhance the potential for 
exposure of the disaster-affected population and emergency workers to 
infections such as dengue, malaria and West Nile fever. Flooding may 
initially flush out mosquito breeding, but this will return when the waters 
recede. Malaria epidemics in the wake of flooding are a well-known 
phenomenon in malaria-endemic areas worldwide. West Nile fever has 
emerged in Europe after heavy rains and flooding, with outbreaks in 
Romania in 1996-97, in the Czech Republic in 1997 and Italy in 1998 
[3]. There is also an increased risk of infection of diseases contracted 
through direct contact with polluted waters, such as wound infections, 
dermatitis, conjunctivitis, and ear, nose and throat infections. 
The effects in developed regions, such as Europe, may be different 
to those in developing regions. The World Health Organization 
Regional Office for Europe has been developing several programmes 
related to assessing the health effects of climate changes, including 
flooding, such as the project Climate Change and Adaptation 
Strategies for Human Health (cCASHh) [11] that covers aspects of 
impact and adaptation assessment for possible climate-related health 
outcomes in Europe. The recent Rapid Health Assessment of Flooding 
in Bulgaria [12], reported in 2005, covers the main public health issues 
that should be considered during and after a flood and is one of the 
most consistent documents on assessing the current situation and 
providing recommendations for local response to flooding. 
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A study in the United States (US) [1] has shown that HIV 
transmission has been occurring within the prison system in 
the state of Georgia. Between July 1988 and February 2005, 88 
prisoners tested HIV-antibody negative at mandatory testing 
on entry to prison, and HIV-antibody positive in a subsequent 
requested test, indicating seroconversion during incarceration. 
Risk behaviours in prison, specifically sex between men and 
tattooing, were associated with HIV seroconversion. The estimated 
HIV prevalence in the US prison population is 2% [2], and a 
number of European countries have a considerably higher prison 
HIV prevalence, in some cases, more than 10% [3]. Considering 
the high HIV prevalence among prisoners in some European 
countries, and the limited number of HIV prevention and harm 
reduction programmes currently in place, the US study highlights 
the need to address and prevent bloodborne virus transmission 
among prisoners in Europe [4]. 
The US study found that those prisoners who had seroconverted to 
HIV were ten times more likely to report sex between men in prison 
than matched controls (adjusted odds ratio [AOR] 10.1, p-value<0.01), 
and fourteen times more likely to have been tattooed while in prison 
(AOR 13.7, p-value=0.01). To a lesser degree, characteristics also 
associated with seroconversion in prison were having a body mass 
index ≤25 kg/m2 on entry to prison (AOR 3.8, p-value=0.02), and 
being of black race (AOR 3.7, p-value=0.03). Prisoners themselves 
suggested that HIV prevention in prisons should include condom 
distribution (38%), HIV education (22%), and safe tattooing practices 
(13%). The study concluded that this clear evidence of transmission 
within the prison system indicated that effective HIV prevention is 
needed in prisons. 
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Injecting drug users and prisons in Europe
HIV prevalence in European prisons has been associated with 
injecting drug use and tattooing [5,6,7,8], but continuing HIV 
transmission within prisons has never been documented. Similar to 
other Western countries, injecting drug users are overrepresented 
among the European prison population [4]. A recent study among 
drug users in 10 European cities reported that 60% had injected drugs 
in the past year and 55% had already been imprisoned [9]. Studies 
indicate that between 8% and 60% of prisoners in Europe have used 
drugs in prison, including intravenously [10]. In common with the 
United States, European prisoners are more likely than the general 
population to be HIV-infected, inject drugs and share injecting 
equipment if they continue to inject in prison [11]. Imprisonment rates 
in western Europe are typically 50-100 per 100 000 population [3]. 
However, in the Russian Federation, the rate is 600 per 100 000 
population [3], second only to the US, where the rate is over 700 per 
100 000 population [12]. 
The prevalence of HIV in European prisons varies between less than 
1% in England to 11% in Portugal and 12% in Estonia [3]. Together 
with high rates of imprisonment among injecting drug users, of whom 
about one half continue to inject in prison, and evidence of other 
risk behaviours for HIV transmission including sex between men 
and tattooing, HIV and its prevention in prisons is of considerable 
importance in Europe. While there is growing evidence that HIV 
transmission in prisons can be reduced [13], current prison HIV 
prevention and harm reduction provision within Europe remains 
scarce and frequently inferior to provision in the community. 
Evidence that harm reduction and prevention programmes in 
prisons are effective
A review of prison-based syringe exchanges in Europe found that, 
overall, reported drug use decreased or remained stable over time, 
and that syringe sharing declined dramatically. In addition, no new 
cases of HIV, hepatitis B or hepatitis C transmission were reported 
[14]. Despite the evidence supporting the value of prison needle 
and syringe exchange, Spain is the only European country with a 
systematic programme [10]. Similarly, other HIV harm reduction 
measures such as substitution treatment, distribution of disinfectant 
tablets and condoms and other evidence based harm reduction 
programmes are lacking or underdeveloped and uncoordinated in 
European prisons. 
The WHO Declaration on Prison Health as Part of Public Health 
calls for equivalent healthcare provision in prisons and the community 
[15]. Nonetheless, prison health in many European countries 
continues to be controversial, with relatively little advocacy for equal 
health protection among prisoners, many of who represent a number 
of marginalised populations including injecting drug users and other 
substance misusers, the homeless, and individuals with complex 
mental health needs. Controversy over healthcare provision in 
prisons has proved a challenge to implementing HIV harm reduction 
strategies, despite increasing recognition that good prison health is 
good public health. Missing the opportunity to address and prevent 
HIV transmission in prisons will result in failure to prevent HIV 
transmission in the community, since most prisoners are eventually 
released from prison and return to being citizens. The opportunity 
to prevent infectious disease, including HIV, in both prisons and the 
community is a significant and frequently unrecognised element of 
public health protection.
Conclusions
The demonstration of HIV transmission in prisons in part of the 
US highlights the following implications for European prisons:
The value of testing programmes for bloodborne viruses that 
disproportionately affect the European prison population by 
screening on reception to and on release from prison, with tests 
available on request throughout the period of imprisonment. 
The importance of implementing HIV and other bloodborne 
•
•
virus prevention interventions in prisons, such as harm reduction 
strategies, to ensure both prison and community public health 
protection, since released prisoners can act as a bridge to the 
community for infectious disease acquired in prison. 
The need for prison-specific advocacy and commitment on the 
political and public health agendas. 
The need to include prison staff in all stages of prevention and 
harm reduction. 
The need for joint efforts by all professionals working in prisons, 
decision makers (such as the relevant government ministries, 
prison administrations, and nongovernmental organisations) 
and international bodies (such as WHO and the United Nations 
Office on Drugs and Crime) to address infectious disease 
prevention in prisons. 
The need to adapt and introduce into prisons harm reduction 
approaches proven to be cost-effective and efficient in the 
community. 
More information on drugs and infections in European prisons 
can be found at http://www.endipp.net, the website of the European 
Network on Drugs and Infections Prevention in Prison (ENDIPP). 
ENDIPP is a Europe-wide, multidisciplinary network that is active in 
all 25 EU member states and accession countries, and co-funded by 
the European Commission’s Public Health Programme.
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